The IBB Trailed All Major ETFs Today, With A Nearly 2% Drop

Arrow down
The iShares Nasdaq Biotechnology Index Fund (IBB) underperformed all other non-leveraged, non-inverse exchange traded products in the U.S. today on a percentage basis, producing a -1.96% one-day return and trailing the wider markets by a total of 1.61 percentage points.
NASDAQ:IBB January 17, 2017 5:16pm

Can Biotechs Recover From Trump’s Strong Condemnation?

From Zacks: The pharma and biotech industry is a victim of concerns over increased regulatory scrutiny on high drug prices over the past two years. The worries cooled down after Trump’s victory, and gave biotech stocks a shot in the arm.
NASDAQ:IBB January 13, 2017 9:13am

Biotech ETFs Could Be Poised For A New Rally

From Taki Tsaklanos: Recently, we spotted the potential of a breakdown in biotechnology stocks, see Biotechnology Stocks Have News For Investors: It is Now or Never. We warned readers to be on the safe side, as a breakdown scenario would be significant.
NASDAQ:IBB January 9, 2017 8:22am

Biotech Downturn Underscored By Lack Of New Drug Approvals

Following the astronomical gains of the previous several years, the biotech industry was hammered in 2016. Behind the decline was a huge downturn in the approval of new medicines.
NASDAQ:IBB January 2, 2017 10:31am

These Biotech Plays More Than Doubled This Year

From Zacks: 2016 has not been a great year for biotech stocks which were under intense pressure with issues like increasing political and media focus on high price tags for drugs and the changing competitive scenario weighing on the sector.
NASDAQ:IBB December 22, 2016 11:18am

Biotechs Are In Danger Of Entering A Bear Market

From Taki Tsaklanos: Biotechnology stocks have important news for investors. They are on the verge of a breakdown. In simple terms: if the biotechnology stock index goes slightly lower from today’s levels, the sector will be in deep trouble as it will enter a tactical bear market.
NASDAQ:IBB December 12, 2016 11:24am

Biotech Stocks Plunge As Trump Vows To Lower Drug Prices

The iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) was on the decline this morning, after Donald Trump's TIME Person of the Year profile revealed that the president-elect likely won't be the bullish force for drug companies many thought he'd be.
NASDAQ:IBB December 7, 2016 9:18am

Biotechs Look Dangerous Again As Trump Rally Fades

Arrow down
Biotech ETFs were initially among the biggest winners of Donald Trump's surprise election win last month, but the early euphoria has now turned to a massive sell-off once again.
NASDAQ:IBB December 2, 2016 8:23am

These ETFs Are The Best And Worst Performers Since Trump’s Victory

Image of blue arrow pointing up
From Zacks: Wall Street welcomed the surprise victory of Republican Donald Trump and the outcome was not bad as expected. This is especially true as the major indices logged in more than 1% gains following the results, reflecting a dramatic reversal from the knee-jerk panic seen in global markets overnight when Trump showed a stunning advance in votes.
NASDAQ:IBB November 10, 2016 12:06pm

Here’s Why Biotech Is Underperforming So Badly Right Now

From Tony Daltorio: There’s been no stock market sector “sicker” in 2016 than the pharma and biotech sectors. The S&P Pharmaceuticals Select Industry Index is down a whopping 22.5% over the past 52 weeks, while the S&P Biotechnology Select Industry Index fell nearly 24% over the same time frame.
NASDAQ:IBB November 8, 2016 3:44pm

Biotech ETF Testing Critical Support Levels

BiotechFrom Taki Tsaklanos: The health sector has been a sector leader in recent years, driven by a strong uptrend in biotechnology. When stock markets collapsed after the summer of last year, biotech took a hit as well, and ceased being a leader. The sector has struggled since then.
NASDAQ:IBB October 22, 2016 7:00am

BlackRock: Health Care Sector Sell-Off Overdone

Health CareHealth care stocks have suffered as political rhetoric heats up around health care reform. BlackRock's Heidi Richardson suggests the sector may have been over-penalized.
NASDAQ:IBB October 20, 2016 6:20am

Biotech ETFs Have Room to Run, with Several Catalysts Ahead

Biotech pillsThe iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) has recovered nicely from its yearly lows, and there's reason to believe that more gains are on the horizon as well.
NASDAQ:IBB September 30, 2016 10:22am

Biotech ETF Hits Key $300 Level for the First Time in 9 Months

The world's largest biotech etf, the iShares NASDAQ Biotechnology Index (NASDAQ:IBB), closed above the $300 level yesterday for the first time since January.
NASDAQ:IBB September 23, 2016 8:58am

Recommended for You

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories